Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF

被引：0
|
作者：
Carpio, D. [1 ]
Calvino-Suarez, C. [2 ]
Martinez-Cadilla, J. [3 ]
Molina, G. [4 ]
Vazquez-Rey, M. T. [5 ]
Marti, E. [6 ]
Fernandez-Salgado, E. [1 ]
Acosta, M. Barreiro-de [2 ]
Hernandez, V. [3 ]
Echarri, A. [4 ]
Diz-Lois, M. T. [5 ]
Baz, A. [6 ]
机构：
[1] Complejo Hosp Univ Ponevedra, Gastroenterol, Pontevedra, Spain
[2] Complexo Hosp Univ Santiago, Gastroenterol, Santiago De Compostela, Spain
[3] Complexo Hosp Univ Vigo, Gastroenterol, Vigo, Spain
[4] Complexo Hosp Univ Ferrol, Gastroenterol, Ferrol, Spain
[5] Complexo Hosp Univ A Coruna, Gastroenterol, La Coruna, Spain
[6] Hosp Univ Lucus Augusti, Gastroenterol, Lugo, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.536
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P412
引用
收藏
页码：S419 / S420
页数：3
相关论文
共 50 条
  • [21] Higher anti-TNF α trough levels are not associated with increased radiological response in perianal fistulising Crohn's disease: A multicentre study
    Lee, T.
    Gilbert, L.
    Srinivasan, A.
    Lee, A.
    van Langenberg, D.
    Martin, C.
    Ding, N.
    Sparrow, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S449 - S449
  • [22] Validation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulising Crohn's disease
    van Rijn, K.
    Lansdorp, C.
    Tielbeek, J.
    Nio, C.
    Buskens, C.
    D'Haens, G.
    Lowenberg, M.
    Stoker, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S184 - S184
  • [23] Open Label Ustekinumab for the Treatment of Anti-TNFα Refractory Moderate-to-Severe Crohn's Disease
    Rosen, Melissa
    Scherl, Ellen
    Rotman, Stephen
    Bosworth, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S486 - S487
  • [24] The St Vincent's experience of fistulising perianal Crohn's disease in the anti-TNF-α era
    Basnayake, C.
    He, T.
    Qui, T. B.
    Samyue, T.
    Connell, W.
    Lust, M.
    Brown, S.
    Wright, E.
    Kamm, M.
    Bell, S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 127 - 127
  • [25] Efficacy of ustekinumab in patient with Crohn's disease and anti-TNF induced psoriasis
    Moreno-Suarez, Fatima
    del Carmen Salazar-Nievas, Maria
    Aceituno-Madera, Pedro
    Bautista-Martinez, Pablo
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB121 - AB121
  • [26] Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease
    Dussias, N.
    Rizzello, F.
    Calabrese, C.
    Passino, A. Sanna
    Melotti, L.
    Scaioli, E.
    Belluzzi, A.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S528 - S528
  • [27] Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail
    Srinivasan, Ashish
    De Cruz, Peter
    van Langenberg, Daniel R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 561 - 562
  • [28] Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
    Martinez-Montiel, M.
    Piedracoba-Cadahia, Pilar
    Gomez-Gomez, Carlos
    Gonzalo, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (09): : 816 - 817
  • [29] Fistula Healing in Perianal Crohn's Disease - With or Without Anti-TNF Therapy?
    Yassin, N. A.
    Askari, A.
    Ferrari, L.
    Faiz, O.
    Warusavitarne, J.
    Phillips, R.
    Hart, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S273 - S274
  • [30] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
12345